Is Oklo Stock a Buy, Sell, or Hold After Its Nuclear Progress? Oklo's story looks huge, but the stock still needs proof. Find out what has to happen next, what could go wrong, and why this nuclear bet has investors so divided.
Snap Shares Drop As CFO Exit, Job Cuts And Profit Push Weigh On Sentiment Snap stock falls as investors weigh CFO exit, layoffs and restructuring push ahead of May earnings report.
Applied Digital Stock Is Moving Lower: What's Going On? Applied Digital Inc. shares are trading lower on Tuesday, though the stock extended a 723% 12‑month rally into stretched valuation territory.
EXCLUSIVE: Nasdaq 100's 13-Day Surge Is No Fluke — It's A 'New Bull Phase' Signal, Says Ryan Detrick The Nasdaq 100 was positive for 13 straight days, one of the longest streaks ever. Market expert Ryan Detrick breaks down what comes next.
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge Disc Medicine advances therapies for serious blood disorders; a key insider recently trimmed their stake amid strong one-year share gains.
Why Is Velo3D Stock Soaring Tuesday? Discover how Velo3D is driving innovation in motorsports and defense. See why VELO stock is trending with recent gains and bullish momentum.
Alaska Air Anticipates $600 Million In Increased Fuel Cost Alaska Air shares drop after wider-than-expected loss and slight revenue miss, with the airline also suspending full-year guidance.
Is the Slide in Netflix Stock a Buying Opportunity? Netflix shares have been on a roller-coaster ride the past year.
AeroVironment Advances On Multi-Domain Defense Success AeroVironment's LOCUST system demonstrates shipboard capability, highlighting its effectiveness in countering drone threats.
SpaceX Reportedly Meeting With Analysts As Filing Reveals These Financial Details SpaceX, Elon Musk's spaceship and satellite company, is hosting three days of meetings with analysts, Reuters reported.
The Space Race Is Heating Up. Here Are 3 Stocks Worth Watching Right Now. SpaceX isn't the only space company worth watching. It's just the most expensive.
Quest Diagnostics Gains Steam With Partnerships, Lifts Outlook Quest Diagnostics Q1 revenue grew 9.2% as organic volume surged. Discover how new partnerships and AI drove these solid financial results.
Why Is Psyence Biomedical Stock Trading Lower On Tuesday? Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump executive order and news on ibogaine supply.
Prediction Markets Called Tim Cook's Apple CEO Successor—Here's What They Forecast Next Polymarket traders called John Ternus as Apple's next CEO months before the announcement. Here's what they're pricing for his first year running AAPL.
